Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Dec 31;4(4):E69.
doi: 10.1208/pt040469.

Unilamellar vesicles as potential capreomycin sulfate carriers: preparation and physicochemical characterization

Affiliations

Unilamellar vesicles as potential capreomycin sulfate carriers: preparation and physicochemical characterization

Stefano Giovagnoli et al. AAPS PharmSciTech. .

Abstract

The aim of this work was to evaluate unilamellar liposomes as new potential capreomycin sulfate (CS) delivery systems for future pulmonary targeting by aerosol administration. Dipalmitoylphosphatidylcholine, hydrogenated phosphatidylcholine, and distearoylphosphatidylcholine were used for liposome preparation. Peptide-membrane interaction was investigated by differential scanning calorimetry (DSC) and attenuated total internal reflection Fourier-transform infrared spectroscopy (ATIR-FTIR). Peptide entrapment, size, and morphology were evaluated by UV spectrophotometry, photocorrelation spectroscopy, and transmission electron microscopy, respectively. Interaction between CS and the outer region of the bilayer was revealed by DSC and ATIR-FTIR. DSPC liposomes showed enhanced interdigitation when the CS molar fraction was increased. Formation of a second phase on the bilayer surface was observed. From kinetic and permeability studies, CS loaded DSPC liposomes resulted more stable if compared to DPPC and HPC over the period of time investigated. The amount of entrapped peptide oscillated between 10% and 13%. Vesicles showed a narrow size distribution, from 138 to 166 nm, and a good morphology. These systems, in particular DSPC liposomes, could represent promising carriers for this peptide.

PubMed Disclaimer

References

    1. Maher D, Floyd K, Raviglione M. A strategic framework to decrease the burden of TB/HIV. WHO report, World Health Organization/ Communicable Disease/Tuberculosis, 2002; 296.
    1. Vigorita MG, Ottana R, Zappalà C, Maccari R, Pizzimenti FC, Gabrielli G. Halogenated isoniazid derivatives as possible antimy cobacterial and anti-HIV agents-III. IL Farmaco. 1994;49:775–781. - PubMed
    1. Ferrarini P, Manera C, Mori C, Badawneh M, Saccomanni G. Synthesis and evaluation of antimycobacterial activity of 4-phenyl-1,8-naphthyridine derivatives. II Farmaco. 1999;53:741–746. doi: 10.1016/S0014-827X(98)00094-9. - DOI - PubMed
    1. Gursoy A. Liposome-encapsulated antibiotics: Physicochemical and antibacterial properties, a review. STP Pharma Sci. 2000;10(4):285–291.
    1. Deol P, Khuller GK. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim Biophys Acta. 1997;1334:161–172. - PubMed

Publication types

LinkOut - more resources